Real-time enrollment status for this sanfilippo syndrome clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 7:56 AM UTC
| NCT Number | NCT02716246 |
| Recruiting Status | Recruiting |
| Condition | Sanfilippo Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Ultragenyx Pharmaceutical Inc |
| Last Updated on CT.gov | August 21, 2026 (2 weeks ago) |
As of September 6, 2026: Clinical trial NCT02716246 is currently recruiting participants. This phase2 study for sanfilippo syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by Ultragenyx Pharmaceutical Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02716246 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02716246 was last updated 2 weeks ago (August 21, 2026). HelloStudys verifies this status automatically.